Skip to content

Empowering Cancer Survivors Through Information Technology

Empowering Cancer Survivors Through Information Technology

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01593618
Enrollment
53
Registered
2012-05-08
Start date
2007-08-31
Completion date
2012-04-30
Last updated
2017-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Survivor

Keywords

cancer survivor

Brief summary

This is a randomized controlled trial of a web-based informational intervention (UMFollowUp) for adolescent and young adult survivors of childhood cancer to improve cancer knowledge and psychosocial functioning.

Detailed description

Individuals randomly assigned to the control group will receive standard of care for the duration of their participation. This means they will continue to receive information regarding their diagnosis, treatments and ongoing health needs from their provider (no access to website). Individuals randomly assigned to the treatment group will receive access to UMFollowUp, a secure, HIPAA-compliant website. All participants will be asked to complete paper-and-pencil surveys at baseline and 9 months later to determine the impact of the web-based intervention.

Interventions

BEHAVIORALUMFollowUp

Web-based internet resource for self-reported treatment summaries and psychosocial and physical well-being.

OTHERStandard of Care

Patients will receive information regarding their diagnosis, treatments, and ongoing health needs from their provider, but will not be provided access to the website.

Sponsors

Masonic Cancer Center, University of Minnesota
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to 28 Years
Healthy volunteers
No

Inclusion criteria

* History of diagnosis of hematologic malignancy or malignant neoplasm, and in disease free remission at time of recruitment. * Must be English-speaking and have access to a computer with internet access, and must have completed treatment at University of Minnesota Medical Center-Fairview for cancer.

Exclusion criteria

* Individual with significant visual impairments and neurologic/cognitive difficulties which limit their ability to see and under our outcome questionnaires or website content will be excluded from participation.

Design outcomes

Primary

MeasureTime frameDescription
Cancer Knowledge SurveyTime of Enrollment and 9 Months LaterMeasure of patient reported knowledge of their cancer diagnosis, history and treatments.

Secondary

MeasureTime frameDescription
Cancer Rehabilitation Evaluation SystemTime of Enrollment and 9 Months LaterShort Form (SF) Medical Interaction Subscale
Herth Hope IndexTime of Enrollment and 9 Months LaterA measure of self-reported hope.
SF-36 QuestionnaireTime of Enrollment and 9 Months LaterA measure of quality of life.
Health Locus of Control ScaleTime of Enrollment and 9 Months LaterA measure of self-reported locus of control.
State Trait Anxiety InventoryTime of Enrollment and 9 Months LaterA measure of self-reported anxiety.
Multidimensional Scale of Perceived Social SupportTime of Enrollment and 9 Months LaterA measure of self-reported social support.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026